Taketoshi Nara, Kengo Furihata, Kazuma Sato, Takuma Sato, Naoko Honma, Yohei Horikawa et al. Cabozantinib Monotherapy for Metastatic Renal Cell Carcinoma Involving Hemodialysis: Two Case Reports. // IJU Case Reports. – 2026. – DOI: 10.1002/iju5.70291. – URL: https://onlinelibrary.wiley.com/doi/10.1002/iju5.70291?af=R
Taketoshi Nara, Kengo Furihata, Kazuma Sato, Takuma Sato, Naoko Honma, Yohei Horikawa, & Naotake Shimoda (2026). Cabozantinib Monotherapy for Metastatic Renal Cell Carcinoma Involving Hemodialysis: Two Case Reports. IJU Case Reports. https://doi.org/10.1002/iju5.70291
Taketoshi Nara, et al. “Cabozantinib Monotherapy for Metastatic Renal Cell Carcinoma Involving Hemodialysis: Two Case Reports.” IJU Case Reports, 2026. doi:10.1002/iju5.70291.
@article{Nara2026,
title = {Cabozantinib Monotherapy for Metastatic Renal Cell Carcinoma Involving Hemodialysis: Two Case Reports},
author = {Nara, Taketoshi and Furihata, Kengo and Sato, Kazuma and Sato, Takuma and Honma, Naoko and Horikawa, Yohei and Shimoda, Naotake},
journal = {IJU Case Reports},
year = {2026},
doi = {10.1002/iju5.70291},
url = {https://onlinelibrary.wiley.com/doi/10.1002/iju5.70291?af=R}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...